Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wassim Abida

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2020
Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in <i>BRCA2</i>-altered Prostate TumorsGoutam Chakraborty, Nabeela Khan Patail, Rahim Hirani, et al.
European Urology|September 19, 2022
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate CancerEthan S Barnett, Nikolaus Schultz, Konrad H Stopsack, et al.
Nature|June 15, 2017
ERF mutations reveal a balance of ETS factors controlling prostate oncogenesisRohit Bose, Wouter R Karthaus, Joshua Armenia, et al.
Science (New York, N.Y.)|May 2, 2020
Regenerative potential of prostate luminal cells revealed by single-cell analysisWouter R Karthaus, Matan Hofree, Danielle Choi, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
JCO Precision Oncology|August 29, 2020
Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene AlterationsJose Mauricio Mota, Ethan Barnett, Jones T Nauseef, et al.
The Prostate|May 10, 2022
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data qualityNiamh M Keegan, Samantha E Vasselman, Ethan S Barnett, et al.
European Urology|October 15, 2022
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with RucaparibAndrea Loehr, Arif Hussain, Akash Patnaik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer ProgressionGoutam Chakraborty, Joshua Armenia, Ying Z Mazzu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate CancerKonrad H Stopsack, Joseph Vijai, Michael Conry, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2020
Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in <i>BRCA2</i>-altered Prostate TumorsGoutam Chakraborty, Nabeela Khan Patail, Rahim Hirani, et al.
European Urology|September 19, 2022
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate CancerEthan S Barnett, Nikolaus Schultz, Konrad H Stopsack, et al.
Nature|June 15, 2017
ERF mutations reveal a balance of ETS factors controlling prostate oncogenesisRohit Bose, Wouter R Karthaus, Joshua Armenia, et al.
Science (New York, N.Y.)|May 2, 2020
Regenerative potential of prostate luminal cells revealed by single-cell analysisWouter R Karthaus, Matan Hofree, Danielle Choi, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
JCO Precision Oncology|August 29, 2020
Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene AlterationsJose Mauricio Mota, Ethan Barnett, Jones T Nauseef, et al.
The Prostate|May 10, 2022
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data qualityNiamh M Keegan, Samantha E Vasselman, Ethan S Barnett, et al.
European Urology|October 15, 2022
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with RucaparibAndrea Loehr, Arif Hussain, Akash Patnaik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer ProgressionGoutam Chakraborty, Joshua Armenia, Ying Z Mazzu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate CancerKonrad H Stopsack, Joseph Vijai, Michael Conry, et al.
Pageof 9